These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36940751)

  • 1. Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems.
    Hakim A; Guido B; Narsineni L; Chen DW; Foldvari M
    Adv Drug Deliv Rev; 2023 May; 196():114781. PubMed ID: 36940751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.
    Osborne A; Khatib TZ; Songra L; Barber AC; Hall K; Kong GYX; Widdowson PS; Martin KR
    Cell Death Dis; 2018 Sep; 9(10):1007. PubMed ID: 30258047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?
    Guo Y; Johnson E; Cepurna W; Jia L; Dyck J; Morrison JC
    Exp Eye Res; 2009 Dec; 89(6):921-33. PubMed ID: 19682984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics.
    Van de Velde S; De Groef L; Stalmans I; Moons L; Van Hove I
    Prog Neurobiol; 2015 Aug; 131():105-19. PubMed ID: 26093354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention.
    Vernazza S; Oddone F; Tirendi S; Bassi AM
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
    Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
    Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of a dual ET
    Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR
    Mol Vis; 2022; 28():165-177. PubMed ID: 36274816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma.
    Wójcik-Gryciuk A; Gajewska-Woźniak O; Kordecka K; Boguszewski PM; Waleszczyk W; Skup M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthetic Preconditioning as Endogenous Neuroprotection in Glaucoma.
    Chou TH; Musada GR; Romano GL; Bolton E; Porciatti V
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method to quantify regional axonal transport blockade at the optic nerve head after short term intraocular pressure elevation in mice.
    Korneva A; Schaub J; Jefferys J; Kimball E; Pease ME; Nawathe M; Johnson TV; Pitha I; Quigley H
    Exp Eye Res; 2020 Jul; 196():108035. PubMed ID: 32353427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration.
    Kimura A; Namekata K; Guo X; Harada C; Harada T
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27657046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models.
    Wang X; Lin J; Arzeno A; Choi JY; Boccio J; Frieden E; Bhargava A; Maynard G; Tsai JC; Strittmatter SM
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1357-66. PubMed ID: 25655801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Looking into the future: Gene and cell therapies for glaucoma.
    Komáromy AM; Koehl KL; Park SA
    Vet Ophthalmol; 2021 Mar; 24 Suppl 1(Suppl 1):16-33. PubMed ID: 33411993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma.
    Risner ML; Pasini S; McGrady NR; Calkins DJ
    Mol Neurobiol; 2022 Mar; 59(3):1366-1380. PubMed ID: 34984584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria.
    Kimball EC; Pease ME; Steinhart MR; Oglesby EN; Pitha I; Nguyen C; Quigley HA
    Exp Eye Res; 2017 Jul; 160():106-115. PubMed ID: 28414059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma.
    Nam MH; Stankowska DL; Johnson GA; Nahomi RB; Pantcheva MB; Nagaraj RH
    Cell Death Dis; 2022 Nov; 13(11):958. PubMed ID: 36379926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dark phase intraocular pressure elevation and retinal ganglion cell degeneration in a rat model of experimental glaucoma.
    Kwong JM; Vo N; Quan A; Nam M; Kyung H; Yu F; Piri N; Caprioli J
    Exp Eye Res; 2013 Jul; 112():21-8. PubMed ID: 23603611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.